JORDAN JULIE (Chief Medical Officer) received a stock award from NEUROGENE INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/24/2026ACC: 0001968554-26-000002
Officer· Chief Medical Officer
Since Feb 2026
+34.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
34.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+4.90K
Price / share
—
Trade value
—
% of position
58.3%
2/20/2026
8.40K→13.30K
Total
Net shares
+4.90K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/20/2026 | A · Award | +4.90K | — | — | 58.3% | 8.40K | 13.30K |
| Total | +4.90K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
29.60K shares
Shares
+29.60K
Strike price
17.64
Held after
29.60K
Exercisable
—
2/20/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock29.60K shares | 2/20/2026 | A · Award | +29.60K | 17.64 | — | 29.60K |